A cost-utility analysis of a rehabilitation service for people living with and beyond cancer.
BMC Health Serv Res. 2014.
PMID: 25407558
Free PMC article.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2014 | 1 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Search Results
4 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
A cost-utility analysis of a rehabilitation service for people living with and beyond cancer.
BMC Health Serv Res. 2014 Nov 19;14:558. doi: 10.1186/s12913-014-0558-5.
BMC Health Serv Res. 2014.
PMID: 25407558
Free PMC article.
BACKGROUND: We conducted a wait-list control randomised trial of an outpatient rehabilitation service for people living with and beyond cancer, delivered in a hospice day care unit. ...METHODS: Forty-one participants were recruited into t …
BACKGROUND: We conducted a wait-list control randomised trial of an outpatient rehabilitation service for people liv …
Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial.
Trials. 2024 Apr 2;25(1):228. doi: 10.1186/s13063-024-08062-4.
Trials. 2024.
PMID: 38566197
Free PMC article.
BACKGROUND: Two million people in the UK are living with or beyond cancer and a third of them report poor quality of life (QoL) due to problems such as fatigue, fear of cancer recurrence, and concerns about returning to work. ...We will assess w …
BACKGROUND: Two million people in the UK are living with or beyond cancer and a third of them report poor qualit …
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Health Technol Assess. 2019 Nov;23(62):1-94. doi: 10.3310/hta23620.
Health Technol Assess. 2019.
PMID: 31690402
Free PMC article.
Clinical Trial.
OBJECTIVES: To assess the risks, benefits and cost-effectiveness of prophylactic levofloxacin in newly diagnosed symptomatic myeloma patients. ...WHAT IS THE PROBLEM? Myeloma is a type of cancer that develops from cells in the bone marrow, called plasma cells, which …
OBJECTIVES: To assess the risks, benefits and cost-effectiveness of prophylactic levofloxacin in newly diagnosed symptomatic myeloma …
A cluster randomised controlled trial to test the effectiveness and cost-effectiveness of a self-management intervention to support women with breast cancer to return to work: A study protocol.
Contemp Clin Trials. 2026 Feb;161:108185. doi: 10.1016/j.cct.2025.108185. Epub 2025 Dec 15.
Contemp Clin Trials. 2026.
PMID: 41407101
INTRODUCTION: Women living with and beyond breast cancer (LWBBC) often experience challenges in returning to work (RTW) because of disease and treatment-related side effects. ...DISCUSSION: Findings will determine whether CanWork is an effective and cost …
INTRODUCTION: Women living with and beyond breast cancer (LWBBC) often experience challenges in returning to work (RTW) …
Cite